These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2311061)

  • 1. A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer.
    Elliott TE; Moertel CG; Wieand HS; Hahn RG; Gerstner JB; Tschetter LK; Mailliard JA
    Cancer; 1990 Apr; 65(7):1491-4. PubMed ID: 2311061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
    Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
    Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
    Içli F; Karaoguz H; Akbulut H; Dinçol D; Demirkazik A; Cay F
    J Surg Oncol; 1997 Apr; 64(4):318-23. PubMed ID: 9142190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
    Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
    Haim N; Tsalik M; Robinson E
    Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trial.
    Lacave AJ; Barón FJ; Antón LM; Estrada E; De Sande LM; Palacio I; Esteban E; Gracia JM; Buesa JM; Fernández OA
    Ann Oncol; 1991; 2(10):751-4. PubMed ID: 1801881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
    Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
    J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
    Yildiz R; Kalender ME; Dane F; Sevinc A; Gumus M; Camci C; Alici S; Kaya AO; Yaman E; Ozturk B; Coskun U; Benekli M; Uncu D; Buyukberber S
    J Oncol Pharm Pract; 2010 Sep; 16(3):173-8. PubMed ID: 19833685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
    Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the treatment of gastric carcinoma.
    Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
    Lerner A; Gonin R; Steele GD; Mayer RJ
    J Clin Oncol; 1992 Apr; 10(4):536-40. PubMed ID: 1548518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
    Thuss-Patience PC; Kretzschmar A; Repp M; Kingreen D; Hennesser D; Micheel S; Pink D; Scholz C; Dörken B; Reichardt P
    J Clin Oncol; 2005 Jan; 23(3):494-501. PubMed ID: 15659494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)].
    Adenis A
    Bull Cancer; 1994 Apr; 81(4):331-3. PubMed ID: 7703551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
    Içli F; Celik I; Aykan F; Uner A; Demirkazik A; Ozet A; Ozgüroğlu M; Taş F; Akbulut H; Firat D
    Cancer; 1998 Dec; 83(12):2475-80. PubMed ID: 9874451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
    Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
    J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.